help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Portela-Gomes, G. M.
Right arrow Articles by Grimelius, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Portela-Gomes, G. M.
Right arrow Articles by Grimelius, L.
(American Journal of Pathology. 2000;157:1299-1309.)
© 2000 American Society for Investigative Pathology

Regular Articles

Synaptic Vesicle Protein 2, A New Neuroendocrine Cell Marker

Guida Maria Portela-Gomes*, Agneta Lukinius{dagger} and Lars Grimelius{dagger}

From the Centres of Gastroenterology and Nutrition,*
University of Lisbon, Lisbon, Portugal; and the Department of Pathology,{dagger}
University Hospital, Uppsala, Sweden

Synaptic vesicle protein 2 (SV2) is a glycoprotein identified in the nervous system of several species, including man, but its occurrence in the human neuroendocrine (NE) cell system has not been investigated. By using a monoclonal antibody to SV2, immunoreactivities were demonstrated in NE cell types in human gastrointestinal tract, pancreas, anterior pituitary gland, thyroid, parathyroid, and adrenal medulla, and also in chief cells of gastric oxyntic mucosa. Immunoelectron microscopy of pancreatic islets revealed SV2 immunoreactivity in secretory granules. Comparison of SV2, synaptophysin, and chromogranin A immunoreactivity showed more SV2- and synaptophysin- than chromogranin A-immunoreactive cells in the antrum and pancreas. In the other gastrointestinal regions and in the other endocrine organs more SV2- than synaptophysin-immunoreactive cells were seen. More chromogranin A- than SV2-immunoreactive cells were observed in duodenum, colon, and parathyroid. Various NE tumors were examined and all contained SV2-immunoreactive cells. The staining patterns with the three markers agreed well, except in hindgut carcinoids, which showed strong SV2 immunoreactivity, weak synaptophysin but no chromogranin A immunostaining. In pituitary adenomas more cells were immunoreactive to SV2 than to the other two antibodies. In conclusion, SV2 is recognized as a further broad marker for NE cells and widens the arsenal of diagnostic tools for NE tumors. It is of special importance for identifying hindgut carcinoids.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
P. Bumming, O. Nilsson, H. Ahlman, A. Welbencer, M. K Andersson, K. Sjolund, and B. Nilsson
Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype
Endocr. Relat. Cancer, September 1, 2007; 14(3): 853 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
S. Ekeblad, B. Nilsson, M. H. Lejonklou, T. Johansson, P. Stalberg, O. Nilsson, H. Ahlman, and B. Skogseid
Gastrointestinal stromal tumors express the orexigen ghrelin.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 963 - 970.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. Iezzi, S. Theander, R. Janz, C. Loze, and C. B. Wollheim
SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment
J. Cell Sci., December 1, 2005; 118(23): 5647 - 5660.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.